ORCID Profile
0000-0002-7664-1571
Current Organisations
Monash University
,
Eijkman Research Center for Molecular Biology, BRIN
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Faculty of Medicine, Universitas Indonesia
Date: 05-2012
Publisher: Informa UK Limited
Date: 05-04-2023
Publisher: American Scientific Publishers
Date: 04-2017
Publisher: MDPI AG
Date: 08-10-2022
DOI: 10.3390/V14102216
Abstract: After its first detection in 1996, the highly pathogenic avian influenza A(H5Nx) virus has spread extensively worldwide. HPAIv A(H5N1) was first detected in Indonesia in 2003 and has been endemic in poultry in this country ever since. However, Indonesia has limited information related to the phylodynamics of HPAIv A(H5N1) in poultry. The present study aimed to increase the understanding of the evolution and temporal dynamics of HPAIv H5N1 in Indonesian poultry between 2003 and 2016. To this end, HPAIv A(H5N1) hemagglutinin sequences of viruses collected from 2003 to 2016 were analyzed using Bayesian evolutionary analysis s ling trees. Results indicated that the common ancestor of Indonesian poultry HPAIv H5N1 arose approximately five years after the common ancestor worldwide of HPAI A(H5Nx). In addition, this study indicated that only two introductions of HPAIv A(H5N1) occurred, after which these viruses continued to evolve due to extensive spread among poultry. Furthermore, this study revealed the ergence of H5N1 clade 2.3.2.1c from H5N1 clade 2.3.2.1b. Both clades 2.3.2.1c and 2.3.2.1b share a common ancestor, clade 1, suggesting that clade 2.3.2.1 originated and erged from China and other Asian countries. Since there was limited sequence and surveillance data for the HPAIv A(H5N1) from wild birds in Indonesia, the exact role of wild birds in the spread of HPAIv in Indonesia is currently unknown. The evolutionary dynamics of the Indonesian HPAIv A(H5N1) highlight the importance of continuing and improved genomic surveillance and adequate control measures in the different regions of both the poultry and wild birds. Spatial genomic surveillance is useful to take adequate control measures. Therefore, it will help to prevent the future evolution of HPAI A(H5N1) and pandemic threats.
Publisher: Public Library of Science (PLoS)
Date: 08-2018
Publisher: MDPI AG
Date: 27-04-2023
DOI: 10.3390/LIFE13051100
Abstract: The Hajj and Umrah are the annual mass gatherings of Muslims in Saudi Arabia and increase the transmission risk of acute respiratory infection. This study describes influenza infection among pilgrims upon arrival in Indonesia and the genetic characterization of imported influenza A/H3N2 virus. In total, 251 swab s les with influenza-like illness were tested using real-time RT-PCR for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and influenza viruses. Complete sequences of influenza A/H3N2 HA and NA genes were obtained using DNA sequencing and plotted to amino acid and antigenicity changes. Phylogenetic analysis was performed using a neighbour-joining method including the WHO vaccine strains and influenza A/H3N2 as references. The real-time RT-PCR test detected 100 (39.5%) s les positive with influenza with no positivity of MERS-CoV. Mutations in the HA gene were mainly located within the antigenic sites A, B, and D, while for the NA gene, no mutations related to oseltamivir resistance were observed. Phylogenetic analysis revealed that these viruses grouped together with clades 3C.2 and 3C.3 however, they were not closely grouped with the WHO-recommended vaccine (clades 3C.1). Sequences obtained from Hajj and Umrah pilgrims were also not grouped together with viruses from Middle East countries but clustered according to years of collection. This implies that the influenza A/H3N2 virus mutates continually across time.
Publisher: IOP Publishing
Date: 12-2021
DOI: 10.1088/1755-1315/948/1/012079
Abstract: Rickettsiosis, caused by Rickettsia species, is one of the old arthropod-borne illness that commonly found in humans and animals. One of the barriers to rickettsiosis control is the intricacy and time-consuming nature of rickettsiosis laboratory diagnosis. This study aimed to establish quantitative real-time PCR targeting the gltA gene for the DNA differentiation of Rickettsia spp. and Ricketsia felis . The collection of cat flea was extracted to acquire the DNA of Rickettsia. Primers were designed based on the analysis of Rickettsia glt A gene sequences. The confirmation of R. felis was performed by sequencing of PCR product. BLAST analysis was done to confirm the closest similarity of the sequences. Results of this study highlighted the melting temperature was reached at 78,5 °C for Rickettsia spp. and 76.5+0.5 °C for Rickettsia felis . The melting peak temperatures were significantly different between Rickettsia spp. and R. felis (p .05). The findings of this work are crucial in the development of powerful diagnostic procedures for detecting and distinguishing Rickettsia spp. and R. felis species.
Publisher: Badan Penelitian dan Pengembangan Kesehatan
Date: 19-10-2018
Abstract: Abstrak Latar Belakang: Vaksinasi merupakan salah satu cara efektif dalam mengontrol dan mengurangi beban penyakit yang disebabkan oleh Influenza. Akan tetapi, efikasi vaksin bisa bervariasi jika strain yang digunakan untuk vaksin berbeda dengan strain yang bersirkulasi di dunia. Hal ini menunjukan pentingnya melakukan analisa prediksi efikasi vaksin. Pada studi ini, prediksi efikasi vaksin Influenza A/H3N2 dilakukan berdasarkan perhitungan antigenic distance strain vaksin WHO dengan virus influenza yang berasal dari jemaah Haj iIndonesia pada tahun 2013. Metode: Sekuensing gen HA dilakukan terhadap dua s el tersimpan yang terkonfirmasi positif Influenza A/ H3N2 yang berasal dari jemaah Haji Indonesia tahun 2013. Pepitope Calculator digunakan untuk menghitung antigenic distance dari dua strain virus influenza dan dilanjutkan dengan perhitungan Pepitope value. Vaksin strain yang direkomendasikan oleh WHO A/Texas/50/2012, A/Switzerland/9715293/2013, A/HongKong/4801/2014 dan dua virus yang diambil dari jemaah Haji Indonesia pada tahun 2013 dianalisa pada studi ini. Hasil: Prediksi efikasi vaksin yang direkomendasikan WHO tahun 2013 (A/Texas/50/2012) dengan s el yang berasal dari jemaah Haji Indonesia tahun 2013 menunjukkan hasil lebih rendah dibandingkan dengan strain vaksin untuk musim flu pada tahun selanjutnya. Hasil ini sesuai dengan hasil analisis filogenetik dan perbandingan asam amino dimana s el pada studi ini berkerabat lebih dekat dengan strain vaksin untuk musim flu selanjutnya dengan perbedaan asam amino yang lebih sedikit di bagian epitope protein HA dibandingkan dengan vaksin tahun 2013. Kesimpulan: Perhitungan efikasi vaksin menggunakan antigenic distance antara strain vaksin WHO dan virus yang menginfeksi jemaah haji Indonesia pada tahun 2013 menunjukkan hasil yang rendah. (Health Science Journal of Indonesia 2018 (1):1-7) Keywords: Efikasi vaksin, Influenza A/H3N2, jemaah Haji, Indonesia Abstract Background: Influenza vaccination is an effective approach to control and reduce the disease burden of influenza viruses. However, the efficacy of influenza vaccine varies every year due to the different antigenic distance between vaccine and the circulating influenza strains globally and therefore necessitates the study of vaccine efficacy (VE). This study describes the prediction of Influenza A/H3N2 VE based on antigenic distances WHO vaccine strains and the virus obtained from Indonesian Hajj pilgrims in 2013. Methods: Coding between Sequence of HA gene of Influenza A/H3N2 virus was obtained from archival s les of Indonesian Hajj Pilgrims in 2013. Pepitope value calculation using Pepitope Calculator to measure the antigenic distance of HA sequences of two influenza strains was implemented. The HA sequences of WHO vaccine strains: A/ Texas/50/2012, A/Switzerland/9715293/2013, A/HongKong/4801/2014 and two influenza viruses from Indonesian Hajj pilgrims in 2013 were analyzed. Results: This study predicted that influenza vaccine strain recommended by WHO for 2013 (A/Texas/50/2012) have low efficacy to the influenza virus obtained from Indonesian Hajj Pilgrim in 2013 while showing higher efficacy to vaccine strain recommended for the following year. This result was in line with phylogenetic analysis and amino acid differences in which the s les in this study were grouped together with vaccine strain in following years and had less amino acid differences in epitope located in HA protein compared with 2013 vaccine strain. Conclusion: The prediction of VE using the antigenic distance measurement between WHO vaccine strain and Indonesian Hajj pilgrim collected in 2013, is considered low. (Health Science Journal of Indonesia 2018 (1):1-7) Keywords: Vaccine efficacy, influenza A/H3N2 virus, Hajj pilgrim, Indonesia
Publisher: Wiley
Date: 13-10-2015
DOI: 10.1111/IRV.12326
Publisher: Cold Spring Harbor Laboratory
Date: 04-02-2022
DOI: 10.1101/2022.02.02.22270351
Abstract: Inactivated SARS-CoV-2 vaccine has been included in the national COVID-19 vaccination program in Indonesia since January 2021. The study aims to assess the impacts of inactivated COVID-19 vaccine on infection, hospitalization, and death among adult population aged ≥18 years in Bali, Indonesia. Test-negative, case control study was conducted by linking SARS-CoV-2 laboratory records, vaccination, and health administrative data for the period of January 13 to June 30, 2021. Case-subjects were defined as in iduals who had a positive RT-PCR test for SARS-CoV-2 during the period they were matched with controls (tested negative) (1:1) based on age, sex, district of residence, and week of testing. We estimated the odds of vaccination in PCR confirmed, hospitalization and death due to COVID-19, accounting for the presence of comorbidities and prior infection. Vaccine effectiveness was estimated as (1-odds ratio) x 100%. Total 109,050 RT-PCR test results were retrieved during the January 13 to June 30, 2021. Of these, 14,168 subjects were eligible for inclusion in the study. Total 5518 matched case-control pairs were analyzed. Adjusted vaccine effectiveness (VE) against laboratory-confirmed SARS-CoV-2 infection was 14.5% (95% confidence interval -11 to 34.2) at 0-13 days after the first dose 66.7% (95% CI: 58.1-73.5) at ≥14 days after the second dose. The adjusted effectiveness against hospitalization and COVID-19-associated death was 71.1% (95% CI: 62.9-77.6) and 87.4% (95% CI: 65.1-95.4%) at ≥14 days after receiving the second dose, respectively. Two-dose of inactivated CoronaVac vaccine showed high effectiveness against laboratory confirmed COVID-19 infection, hospitalization, and death associated with COVID-19 among adults aged ≥18 years.
Publisher: AIP Publishing
Date: 2021
DOI: 10.1063/5.0052866
Publisher: ScopeMed
Date: 15-03-2019
DOI: 10.5799/JMID.537178
Publisher: Kesmas: Jurnal Kesehatan Masyarakat Nasional
Date: 31-08-2016
Publisher: Elsevier BV
Date: 04-2014
Publisher: Elsevier BV
Date: 12-2020
Location: Indonesia
Location: Indonesia
No related grants have been discovered for Agustiningsih Agustiningsih.